Interactive Investor
>>

Recce Pharmaceuticals Ltd (ASX:RCE) Share Price

RCE

Recce Pharmaceuticals Ltd

APAC company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

 / 

- / -
-
- / -
-
-
-

NAV Price

-

Last Traded

-

Chg

-

-

XASX

-

Updated: -

Loading...

Times are shown in GMT+10, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Recce Pharmaceuticals Ltd is an Australia-based globally-focused biotechnology company engaged in the development and commercialization of a new class of antibiotics. It operates in only one business segment being research and development of pharmaceutical drugs. The firm operates in three geographic segments being Australia, the United Kingdom, and the United States of America, of which the majority of the revenue comes from Australia. The company offers antibiotic drugs to treat the diseases caused by various bacterias namely Sepsis, Helicobacter Pylori, Escherichia coli, Pseudomonas aeruginosa, and others.Recce Pharmaceuticals Ltd is engaged in synthetic polymer-antibiotics. The company has expertise in research and development of pharmaceutical drugs that kill germs and also involved synthesized and patented RECCE antibiotics.

ASX:RCE

AU000000RCE5

AUD

Loading...

Loading Comparison

Latest RCE News

Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News